ArticleBiomedicines2022

Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo.

Weiming Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.